PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25763784-5	2015	RESULTS: The use of DMPA or NuvaRing was associated with reduced capacity of circulating pDCs to produce interferon (IFN)-alpha and tumor necrosis (TNF-alpha) in response to TLR-9 stimulation.	Medroxyprogesterone Acetate	20-24	interferon alpha 1	Homo sapiens	105-127	
25763784-6	2015	Systemic levels of IFN-alpha and cervicovaginal fluid levels of IFN-alpha, CXCL10, monocyte chemotactic protein-1, and granulocyte-colony stimulating factor were significantly lower in DMPA users compared to control volunteers not using hormonal contraception.	Medroxyprogesterone Acetate	185-189	interferon alpha 1	Homo sapiens	19-28	
25763784-6	2015	Systemic levels of IFN-alpha and cervicovaginal fluid levels of IFN-alpha, CXCL10, monocyte chemotactic protein-1, and granulocyte-colony stimulating factor were significantly lower in DMPA users compared to control volunteers not using hormonal contraception.	Medroxyprogesterone Acetate	185-189	interferon alpha 1	Homo sapiens	64-73	
23354099-6	2013	Women using DMPA displayed lower levels of IFNalpha in plasma and genital secretions compared with controls with no hormonal contraception.	Medroxyprogesterone Acetate	12-16	interferon alpha 1	Homo sapiens	43-51	
9185717-5	1997	A 6-day pretreatment of CG-5 cells with nIFN-alpha, at the above-mentioned doses, sensitized them to the growth-inhibiting activity of subsequent exposure to 10(-7) M TAM or MPA, which resulted in a synergistic effect, and could be explained on the basis of the observed enhancement of estrogen and progesterone receptors due to IFN activity.	Medroxyprogesterone Acetate	174-177	interferon alpha 1	Homo sapiens	41-44	
12530040-5	2002	Medroxyprogesterone acetate (MPA) may interfere with IL-6 macrophage production, possibly causing a synergistic effect in association with IL-2 and IFN-alpha.	Medroxyprogesterone Acetate	0-27	interferon alpha 1	Homo sapiens	148-157	
11107678-3	2000	Subsequently, low doses alpha IFN/IL-2 produced a response, and further response have been obtained by the combination of low-doses alpha IFN/IL-2 plus medroxyprogesterone acetate and cis-retinoic acid.	Medroxyprogesterone Acetate	152-179	interferon alpha 1	Homo sapiens	30-33